Ultragenyx Pharmaceutical Inc. buy Bank of America Co.
Start price
31.05.24
/
50%
€37.00
Target price
31.05.25
€70.03
Performance (%)
-20.00%
End price
01.06.25
€29.60
Summary
This prediction ended on 01.06.25 with a price of €29.60. The prediction for Ultragenyx Pharmaceutical Inc. disappointed with a performance of -20.00%. Bank_of_America_Co_ has a follow-up prediction for Ultragenyx Pharmaceutical Inc. where he still thinks Ultragenyx Pharmaceutical Inc. is a Buy. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 4.873% | 4.873% | -33.355% |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target lowered by analysts at Bank of America Co. from $83.00 to $76.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Bank_of_America_Co_ for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€19.80
02.01.26
02.01.26
€49.31
02.01.27
02.01.27
6.57%
17.04.26
17.04.26
